A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
Browsing: Uncategorized
As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
The company is a medical devices company that has developed a novel technology for site directed, electronic driven radiation therapy for the treatment of cancer. The company’s product delivers high doses of radiation directly to tumors using a miniaturized electronic X-ray source, rather than radioactive chemicals. Using this type of electronic radiation source increases the safety of radiation therapy since the radiation can be turned on and off, unlike chemical radiation sources that continuously emit radiation. Furthermore, the company’s product delivers radiation to tumor sites directly, thereby preserving healthy surrounding tissue. The company’s technology enables physicians to more readily treat…
The company is a medical device company that has developed a cutting edge catheter-based drug delivery technology that enables the delivery of drugs to highly specific sites in patients. The company’s technology enables the set-in positioning of catheters at the site of interest, and then infuses drugs into the blood vessels that are leading directly to the tissue that is being targeted. The products ability to precisely target and isolate where in the body drugs are delivered enables physicians to significantly increase drug concentrations all the while reducing systemic side effects, a major treatment goal in cancer where chemotherapy damages…
Father’s Day is just around the corner, but many dads won’t be around to celebrate. Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among men in the U.S.
One type of nanoparticle currently in development engages in “active targeting,” or targeting drugs to cancer cells by attaching them to a molecule that the cancer cell is receptive to.
The company is a medical devices company that has developed an apparatus for advanced diagnostic analysis of cervical tissue, which serves as a routine screening test for women’s cervical cancer. This unique cervical sampling device is able to achieve a 360 degree collection of the entire cervix thereby enhancing the sampling quality and its diagnostic value. This device is poised to replace the traditional Pap smear which is currently used for women’s cervical screening. Click here for more information